NFKB1 and colorectal cancer: Constitutive NF-κB activation has been observed in 66% of colorectal cancer cell lines whereas activating NF-κB mutations commonly occur in hematopoietic tumours (Hassanzadeh, 2011; Xia et al., 2014).